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Purpose

Methods

Implications for Practice

The purpose of this scoping review is to examine
intraoperative dexmedetomidine use to prevent
postoperative delirium (POD) in the elderly (>60 years).

•

• Using the confusion assessment method will aid in identifying
those at risk for POD.
• Dexmedetomidine mitigates cognitive impairment induced by
acute pain, encouraging early ambulation and shortening
length of stay.
• Dexmedetomidine decreases the perception of pain by
decreasing the release of norepinephrine. Decreased pain
leads to decreased usage of opioids.
• Further research is needed with larger sample sizes, proper
screening of patients, and inclusion of providers willing to
participate with the study’s plan of care.

Specific Aims:
• Compare the effectiveness of dexmedetomidine to
opioids in reducing the incidence of postoperative
delirium.
• Determine if the use of dexmedetomidine will
decrease the occurrence of delirium in the elderly in
the first 48 hours after surgery.
• Determine if the use of dexmedetomidine will result in
better patient outcomes in the first 48 hours of the
postoperative period.
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Opioid-induced POD is
a well-recognized entity
leading to increased
length of hospital stays,
increased hospital
costs, and increased
morbidity in the elderly.
Dexmedetomidine is a
potential alternative for
opioids, as it mitigates
cognitive dysfunction
secondary to acute pain compared to standard
opioid-based analgesia.
Dexmedetomidine is an alpha-2 agonist,
delivering sedative and analgesic properties with
fewer negative effects than opioids.
Compared to opioids, dexmedetomidine
decreases the perception of acute pain,
enhances chronic pain management, reduces
the frequency of POD, and has no addictive or
adverse effects.

Database search developed with assistance of the academic
librarian from November 1 to November 15, 2019.
PubMed, CINAHL, PsychINFO, Google Scholar, and scanning of
references

Selection of Sources of Evidence
•
•
•
•

•

Evaluates the efficacy of dexmedetomidine for prevention
of postoperative delirium
Published in the last 5 years (as of 2019)
Peer-reviewed
Published in English
Abstract included
Free access
Study subjects 60 years or older

The Search
•

Background
•

Eligibility Criteria for Articles

9,000 sources initially identified
Each author selected 5 articles for review by co-authors
Created annotated literature tables for easy screening
4 articles excluded; 11 articles included in scoping review

Data Charting
•
•

Developed data-charting form on Microsoft Word
Data items extracted include author(s) of the publication, the year,
the country of origin, the study population, sample size,
methods/interventions, and key findings relating to the scoping
review question

References
Results
Synthesis of Results
81.8% of the studies advocate for the use of dexmedetomidine in
preventing and treating POD and emergence agitation.

Deiner, S., Luo, X., Lin, H.-M., Sessler, D. I., Saager, L., Sieber, F. E., Lee, H. B., Sano, M., Jankowski, C., Bergese, S. D., Candiotti, K.,
Flaherty, J. H., Arora, H., Shander, A., & Rock, P. (2017). Intraoperative infusion of dexmedetomidine for
prevention of postoperative
delirium and cognitive dysfunction in elderly patients undergoing major elective noncardiac surgery. JAMA Surgery, 152(8), e171505.
https://doi.org/10.1001/jamasurg.2017.1505
Duan, X., Coburn, M., Rossaint, R., Sanders, R., Waesberghe, J., & Kowark, A. (2018). Efficacy of perioperative dexmedetomidine on
postoperative delirium: Systematic review and meta-analysis with trial sequential analysis of randomised controlled trials. British Journal of
Anaesthesia, 121(2), 384–397. https://doi.org/10.1016/j.bja.2018.04.046
He, F., Shen, L., & Zhong, J. (2018). A study of dexmedetomidine in the prevention of postoperative delirium in elderly patients after vertebral
osteotomy. Int J Clin Exp Med, 11(5), 4984-4990. http://www.ijcem.com/files/ijcem0075571.pdf
Janssen, TL., Alberts, AR., Hooft, L., Mattace-Raso, F., Mosk, CA., & Van der Laan, L. (2019). Prevention of postoperative delirium in elderly
patients planned for elective surgery: Systematic review and meta-analysis. Clinical Interventions in Aging, 14:1095-1117.
https://doi.org/10.2147/CIA.S201323
Pan, H, Liu, C., Ma, X., Xu, Y., Zhang, M., & Wang, Y. (2019). Perioperative dexmedetomidine reduces delirium in elderly patients after noncardiac surgery: A systematic review and meta-analysis of randomized-controlled trials. Canadian Journal of Anesthesia, 66(12), 1489-1500.
https://doi.org/10.1007/s12630-019-01440-6
Pavone, K. J., Cacchione, P. Z., Polomano, R. C., Winner, L., & Compton, P. (2018). Evaluating the use of dexmedetomidine for the reduction of
delirium: An integrative review. Heart & Lung, 47(6), 591–601. https://doi.org/10.1016/j.hrtlng.2018.08.007
Shi, C., Jin, J., Qiao, L., Li, T., Ma, J., & Ma, Z. (2019). Effect of perioperative administration of dexmedetomidine on delirium
surgery in elderly patients: A double-blinded, multi-center, randomized study. Clinical Interventions in Aging, 14, 571-575.
https://doi.org/10.2147/CIA.S194476

after cardiac

Subramaniam, B., Shankar, P., Shaefi, S., Mueller, A., O’Gara, B., Banner-Goodspeed, V., Gallagher, J., Gasangwa, D., Patxot, M.,
Packiasabathy, S., Mathur, P., Eikermann, M., Talmor, D., & Marcantonio, E. R. (2019). Effect of intravenous acetaminophen vs placebo
combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery: The DEXACET
randomized clinical trial. JAMA, 321(7), 686–696. https://doi.org/10.1001/jama.2019.0234
Zeng H, Li Z, He J, & Fu W. (2019). Dexmedetomidine for the prevention of postoperative delirium in elderly patients undergoing noncardiac
surgery: A meta- analysis of randomized controlled trials. Plos One, 14(8), 1-15. https://doi.org/10.1371/journal.pone.0218088
Zhang, J., Liu, G., Zhang, F., Fang, H., Zhang, D., Liu, S., Chen, B., & Xiao, H. (2019a). Analysis of postoperative cognitive
dysfunction and
influencing factors of dexmedetomidine anesthesia in elderly patients with colorectal cancer. Oncology Letters, 18(3), 3058–3064.
https://doi.org/10.3892/ol.2019.10611
Zhang, J., Yu, Y., Miao, S., Liu, L., Gan, S., Kang, X., & Zhu, S. (2019b). Effects of perioperative intravenous administration of dexmedetomidine
on emergence agitation after general anesthesia in adults: a meta-analysis of randomized controlled trials. Drug Design, Development, and
Therapy, 13:2853-2864. https://doi.org/10.2147/DDDT.S207016

